Literature DB >> 9042475

Cochlear implantation in an intralabyrinthine acoustic neuroma patient after resection of an intracanalicular tumor.

T Tono1, Y Ushisako, T Morimitsu.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9042475     DOI: 10.1159/000058978

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


× No keyword cloud information.
  7 in total

1.  [Intralabyrinthine schwannomas].

Authors:  J Ebmeyer; J Lautermann; L U Scholtz; H Sudhoff
Journal:  HNO       Date:  2011-02       Impact factor: 1.284

2.  Cochlear obliteration following a translabyrinthine approach and its implications in cochlear implantation.

Authors:  B Delgado-Vargas; M Medina; R Polo; A Lloris; M Vaca; C Pérez; A Cordero; I Cobeta
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-11-30       Impact factor: 2.124

3.  Cochlear obliteration after translabyrinthine vestibular schwannoma surgery.

Authors:  Caroline Beutner; Christian Mathys; Bernd Turowski; Jörg Schipper; Thomas Klenzner
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-11       Impact factor: 2.503

4.  Treatment and auditory rehabilitation of intralabyrinthine schwannoma by means of cochlear implants : English version.

Authors:  A Aschendorff; S Arndt; R Laszig; T Wesarg; F Hassepaß; R Beck
Journal:  HNO       Date:  2017-01       Impact factor: 1.284

5.  [Treatment and auditory rehabilitation of intralabyrinthine schwannoma by means of cochlear implants - German Version].

Authors:  A Aschendorff; S Arndt; R Laszig; T Wesarg; F Hassepaß; R Beck
Journal:  HNO       Date:  2017-04       Impact factor: 1.284

6.  CNAP To Predict Functional Cochlear Nerve Preservation in NF-2: Cochlear Implant or Auditory Brainstem Implant.

Authors:  Enrico Piccirillo; Maurizio Guida; Sean Flanagan; Lorenzo Lauda; Paolo Fois; Mario Sanna
Journal:  Skull Base       Date:  2008-07

7.  Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.

Authors:  Jin Won Kim; Ji Hyuk Han; Jin Woong Kim; In Seok Moon
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.